Viral vectors and plasmid DNA manufacturing — the bioproduction of recombinant adeno-associated virus (AAV), lentivirus, adenovirus, and herpes simplex virus vectors along with GMP-grade plasmid DNA substrates for gene therapy, gene-modified cell therapy, and vaccine applications — creating the most capacity-constrained segment in biopharmaceutical manufacturing, with the Viral...